US Patent 9745253 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
Patent 9745253 was granted and assigned to FORMA Therapeutics on August, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9745253 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
